Senior insider sale
Chief Financial Officer at REATA PHARMACEUTICALS INC — senior position signals high conviction
$21.20M
160.18K shares
SONI MANMEET SINGH plans to sell 160.18K shares of REATA PHARMACEUTICALS INC valued at approximately $21.20M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Vesting of restricted stock unit award
Granted as part of issuer equity compensation plan
Vesting of restricted stock unit award
Granted as part of issuer equity compensation plan
Vesting of restricted stock unit award
Granted as part of issuer equity compensation plan
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/15/2023 | Vesting of restricted stock unit award Granted as part of issuer equity compensation plan | 596.00 | — |
7/6/2023 | Vesting of restricted stock unit award Granted as part of issuer equity compensation plan | 388.00 | — |
7/3/2023 | Vesting of restricted stock unit award Granted as part of issuer equity compensation plan | 771.00 | — |
| Total | 1.75K | ||
Completed
Units to sell
75K
Market value
$12.35M
Units to sell
78.08K
Market value
$8.03M
Units to sell
4.71K
Market value
$469.3K
Units to sell
625.00
Market value
$50.6K
Planned — Approximate Date
Units to sell
1.75K
Market value
$295.6K
Units
160.18K
Value
$21.20M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
7/28/2023 | 75K | $12.35M | — | Completed |
6/13/2023 | 78.08K | $8.03M | — | Completed |
6/12/2023 | 4.71K | $469.3K | — | Completed |
5/16/2023 | 625.00 | $50.6K | — | Completed |
| Planned — Approximate Date | ||||
8/16/2023 | 1.75K | $295.6K | NASDAQ | Planned |
| Total | 160.18K | $21.20M | ||